EUCTR2007-004393-81-AT
Active, not recruiting
Phase 1
Prospektive Evaluation von Multimodality Imaging Verfahren (PET - CT - MRT - US - Bildfusion) bei malignen Tumoren der Kopf-Hals-Region
Medizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I)0 sites270 target enrollmentApril 1, 2008
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Patients with malignant Head and Neck Tumors - Diagnostic Imaging Study
- Sponsor
- Medizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I)
- Enrollment
- 270
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?Patienten, die mit einem de\-novo\-Kopf\-Hals\-Tumor auf der HNO\-Klinik vorgestellt werden und klinisch schlüssige Hinweise auf einen malignen Tumor haben.
- •?Patienten mit klinischem Verdacht auf ein Rezidiv eines Kopf\-Hals\-Tumors.
- •?Mindestalter 18 Jahre
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •?Eingriffe im Kopf\-Hals\-Bereich innerhalb von 3 Monaten vor der Bildgebung
- •?Renale Retention mit Kreatininwert \> 1,5 mg/dl (Patienten mit oraler Diabeteseinstellung mit Metformin bei werden bei einem Serumkratininwert \< 1,5 mg/dl und entsprechender Hydrierung laut Guidelines der European Society of Urogenital Radiology eingeschlossen).
- •?Bekannte Allergie auf jodhältige Kontrastmittel
- •?Hyperthyreose
- •?Implantierte elektronische Devices ohne MRT\-Freigabe
- •?Klaustrophobie
- •?Gravidität
- •?Fehlendes Einverständnis zur Teilnahme an der Studie
- •?Fehlende Geschäftsfähigkeit
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2015-000519-42-ITIVERIC bio, Inc.32
Active, not recruiting
Phase 1
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32
Not yet recruiting
Not Applicable
Retrospective analysis of imaging modalities acquired during clinical diagnosis of patients with clinical suspected neurodegenerative Parkinsonian syndromeG20Parkinson diseaseDRKS00016920Klinik und Poliklinik für Nuklearmedizin, LMU München50
Recruiting
Not Applicable
The multimodarity imaging assesssment using MRI and US related to the associaton between the skeletal muscle and the liver.JPRN-UMIN000009557niversity of Tsukuba70
Completed
Not Applicable
Effectiveness of multimodal imaging for the evaluation of retinal oedema and new vessels in diabetic retinopathyProliferative diabetic retinopathy (PDR) and diabetic macular oedema (DMO)Eye Diseases1. Proliferative diabetic retinopathy (PDR)2. Diabetic macular edema (DME)ISRCTN10856638Belfast Health and Social Care Trust401